Filing Flows

Filing Flows › Penumbra (PEN) › Q2 2025

Penumbra (PEN) Q2 2025 earnings results (second quarter 2025)

10-Q filed Jul 29, 2025

Penumbra (PEN) reported revenue of $339M for the second quarter 2025 (Q2 2025), +13% from a year earlier and +5% from the quarter before. Operating margin was 12.0%, net earnings $45.3M (13.3% of revenue).

Revenue$339M
Year over year+13%
Quarter over quarter+5%
Operating margin12.0%
Net earnings$45.3M

Penumbra, Q2 2025: revenue $339M (+13% year over year), operating margin 12.0%, net earnings $45.3M, operating cash flow $44.9M. The chart follows the revenue to costs, profit and cash.

Q2 2025AmountQ/QY/Y
Revenue$339M+5%+13%
Gross profit$224M+4%+38%
Operating profit$40.8M+1%—
Net earnings$45.3M+15%—
Operating cash flow$44.9M-8%+99%
Free cash flow$29.4M-17%+62%

What changed

Revenue was $339.5M in Q2 2025, up 13% year over year and up 5% from the previous quarter. Thrombectomy was the largest line at 68% of revenue. Thrombectomy added $26.8M year over year (up 13%), 67% of the total change.

Gross margin was 66.0%, up 11.6 points from a year earlier. Operating profit was $40.8M, a 12.0% margin (up 39.1 points year over year). Operating expenses fell 25% while revenue rose 13%. The fastest-growing cost line was SG&A (+13%). Net earnings were $45.3M. The effective tax rate was 0.1%.

Operating cash flow was $44.9M (up 99% year over year), 99% of net earnings. Non-cash charges added back $5.5M of depreciation and amortization and $14.2M of share-based compensation. Working capital and other items used $20.1M. Capital expenditures of $15.6M left free cash flow of $29.4M.

Questions

What was Penumbra's revenue in the second quarter 2025?

Penumbra (PEN) reported revenue of $339M for the second quarter 2025 (Q2 2025), +13% from a year earlier and +5% from the quarter before.

Was Penumbra profitable in the second quarter 2025?

Operating profit was $40.8M (12.0% of revenue) and net earnings $45.3M.

Open the interactive Sankey →

Source: Penumbra 10-Q on SEC EDGAR.